Lupus anticoagulant (LA)

0 Azn

Lupus anticoagulant (LA) is a type of antiphospholipid antibody that increases the risk of blood clot formation (thrombosis). It is not specific to lupus (Systemic Lupus Erythematosus - SLE) but is commonly found in patients with antiphospholipid syndrome (APS) and autoimmune diseases.

Clinical Significance

  • LA increases the risk of abnormal blood clotting, leading to deep vein thrombosis (DVT), stroke, and pregnancy complications.
  • It is an important marker in diagnosing APS, which is associated with recurrent pregnancy loss, thrombosis, and autoimmune diseases.
  • Patients with prolonged activated partial thromboplastin time (APTT) are often tested for LA to determine if the cause is LA or another coagulation disorder.
  • Fasting for 2-3 hours before the test (only plain water is allowed).
  • Discontinue heparin and similar medications 5 days before testing (consult with a doctor).
  • Avoid physical and emotional stress; do not smoke for at least 30 minutes before the test.
  • Investigating causes of thrombosis
  • Evaluating unexplained pregnancy loss (miscarriages)
  • Determining if prolonged APTT is due to LA or another clotting disorder
  • Diagnosing antiphospholipid syndrome (APS) (alongside cardiolipin and beta-2 glycoprotein antibodies)
  • Confirming the presence of lupus anticoagulant
  • Assessing clotting disorders in autoimmune diseases

Positive Lupus Anticoagulant Test May Indicate:

  • Autoimmune diseases
  • Systemic lupus erythematosus (SLE)
  • Antiphospholipid syndrome (APS)
  • Rheumatoid arthritis
  • Multiple myeloma
  • Ulcerative colitis
  • Malignancies (cancer, leukemia, lymphoma)
  • Secondary APS (due to infections, medications, or other conditions)
  • Complications from certain medications (e.g., oral contraceptives, certain antibiotics, anticoagulants)